Accessibility Menu
 
Arvinas logo

Arvinas

(NASDAQ) ARVN

Current Price$10.59
Market Cap$651.12M
Since IPO (2018)-37%
5 Year-84%
1 Year+51%
1 Month-20%

Arvinas Financials at a Glance

Market Cap

$651.12M

Revenue (TTM)

$262.60M

Net Income (TTM)

$80.80M

EPS (TTM)

$-1.22

P/E Ratio

-8.37

Dividend

$0.00

Beta (Volatility)

1.43 (Average)

Price

$10.59

Volume

1,144,625.957

Open

$10.26

Previous Close

$10.60

Daily Range

$10.26 - $10.85

52-Week Range

$5.90 - $14.51

ARVN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Arvinas

Industry

Pharmaceuticals

Employees

246

CEO

John G. Houston, PhD

Headquarters

New Haven, CT 06511, US

ARVN Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-44%

Net Income Margin

-31%

Return on Equity

-16%

Return on Capital

-20%

Return on Assets

-11%

Earnings Yield

-11.95%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$651.12M

Shares Outstanding

63.96M

Volume

1.14M

Short Interest

0.00%

Avg. Volume

829.37K

Financials (TTM)

Gross Profit

$257.40M

Operating Income

$114.90M

EBITDA

$75.30M

Operating Cash Flow

$273.80M

Capital Expenditure

$1.90M

Free Cash Flow

$275.70M

Cash & ST Invst.

$685.40M

Total Debt

$8.50M

Arvinas Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$9.50M

-84.0%

Gross Profit

$8.30M

-86.0%

Gross Margin

87.37%

N/A

Market Cap

$651.12M

N/A

Market Cap/Employee

$1.51M

N/A

Employees

430

N/A

Net Income

$67.40M

-49.4%

EBITDA

$66.00M

-16.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$676.90M

-34.3%

Accounts Receivable

$6.40M

-53.3%

Inventory

$0.00

N/A

Long Term Debt

$7.20M

-8.9%

Short Term Debt

$1.90M

+5.6%

Return on Assets

-11.26%

N/A

Return on Invested Capital

-20.09%

N/A

Free Cash Flow

$30.60M

+63.7%

Operating Cash Flow

$30.40M

+63.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
REPLReplimune Group, Inc.
$7.65+6.25%
MGTXMeiraGTx Holdings plc
$8.66+7.05%
ATXSAstria Therapeutics, Inc.
$12.58+0.00%
VALNValneva SE
$6.25+0.97%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$41.68+0.10%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.55-0.11%
QQQInvesco QQQ Trust
$577.18+0.03%
INTCIntel
$44.13+0.07%

Questions About ARVN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.